Document is current
Any future updates will be listed below
-
Authors
Song, Zhuoyi
Bae, Bongmin
Schnabl, Simon
Yuan, Fei
De Zoysa, Thareendra
Akinyi, Maureen V.
Le Roux, Charlotte A.
Choquet, Karine
Whipple, Amanda J.
Van Nostrand, Eric L.
- License Information
-
More Information
Article History
Received: 20 September 2024
Accepted: 13 February 2025
First Online: 25 February 2025
Declarations
:
: Not applicable.
: Not applicable.
: ELVN is co-founder, member of the Board of Directors, on the SAB, equity holder, and paid consultant for Eclipse BioInnovations, on the SAB of RNAConnect, and is inventor of intellectual property owned by University of California San Diego. ELVN’s interests have been reviewed and approved by the Baylor College of Medicine in accordance with its conflict of interest policies. The other authors declare no competing interests.
